David A. Siegel Delcath Systems, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
40Shares Held
7.37MCall Options Held
143KPut Options Held
60.8K-
Aigh Capital Management LLC Baltimore, MD2.36MShares$18.7 Million4.54% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.67MShares$13.2 Million1.06% of portfolio
-
Bvf Inc San Francisco, CA1.2MShares$9.51 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA684KShares$5.41 Million0.0% of portfolio
-
Cibc World Market Inc. Toronto, A6260KShares$2.06 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $68M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...